134 related articles for article (PubMed ID: 1243026)
1. Antihypertensive action of indapamide. Comparative studies in several experimental models.
Kyncl J; Oheim K; Seki T; Solles A
Arzneimittelforschung; 1975 Oct; 25(10):1491-5. PubMed ID: 1243026
[TBL] [Abstract][Full Text] [Related]
2. [Antihypertensive and diuretic effects of indapamide in normotensive and hypertensive rats (author's transl)].
Morishita S; Nishimura K; Kato E; Shirahase H; Osumi S; Kitao K; Seki T
Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):137-46. PubMed ID: 7084816
[TBL] [Abstract][Full Text] [Related]
3. Modification of the antihypertensive effect of indapamide by indomethacin.
Pasnani JS; Gulati OD; Hemavathi KG
Indian J Physiol Pharmacol; 1989; 33(3):146-50. PubMed ID: 2592038
[TBL] [Abstract][Full Text] [Related]
4. Indapamide treatment modifies the vascular reactivity of normotensive rat mesenteric arteries ex vivo.
Tarkkila L; Paakkari I; Mervaala E; Nevala R; Vapaatalo H
Methods Find Exp Clin Pharmacol; 1996; 18(1):5-11. PubMed ID: 8721250
[TBL] [Abstract][Full Text] [Related]
5. The pharmacology and clinical pharmacology of indapamide.
Campbell DB; Moore RA
Postgrad Med J; 1981; 57 Suppl 2():7-17. PubMed ID: 7033951
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
[TBL] [Abstract][Full Text] [Related]
7. [Antihypertensive action of indapamide in hypertension of chronic renal failure].
Meyrier A; Condamin MC
Ann Cardiol Angeiol (Paris); 1994 Jan; 43(1):43-8. PubMed ID: 8172477
[TBL] [Abstract][Full Text] [Related]
8. Alteration of renal receptors for atrial natriuretic peptide and vasopressin in spontaneously hypertensive rats treated with antihypertensive diuretics.
Ogura T; Nishida N; Watanabe H; Omiya T; Yamauchi T; Hosoya M; Hirata H; Kashihara N; Ota Z
Res Commun Chem Pathol Pharmacol; 1994 Feb; 83(2):165-78. PubMed ID: 8202630
[TBL] [Abstract][Full Text] [Related]
9. Indapamide: clinical pharmacology, therapeutic efficacy in hypertension, and adverse effects.
Mroczek WJ
Pharmacotherapy; 1983; 3(2 Pt 1):61-7. PubMed ID: 6856486
[TBL] [Abstract][Full Text] [Related]
10. Effect of indapamide on an experimental model of cerebral ischemia in hypertensive rats.
Delbarre B; Delbarre G
Am J Med; 1988 Jan; 84(1B):20-5. PubMed ID: 3341387
[TBL] [Abstract][Full Text] [Related]
11. Effects of combination of low doses of angiotensin-converting enzyme inhibitor and diuretics on renal function in spontaneously hypertensive rats: comparison between acute and chronic treatment.
Doucet J; Richard V; Mulder P; Henry JP; Schiavi P; Guez D; Thuillez C
J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):107-11. PubMed ID: 11881108
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive effect of indapamide.
Gragnoli G; Puccetti F; Nami R; Tanganelli I; Favilli R; Betti E
Minerva Med; 1977 Mar; 68(12):749-60. PubMed ID: 846677
[TBL] [Abstract][Full Text] [Related]
13. Diuretic agents related to indapamide. IV--Synthesis and pharmacological activity of N-(4-chloro-3-sulfamoylbenzamido)-methyl-phenyl-pyrrolidines and N1-(4-chloro-3-sulfamoylbenzoyl)-N2-aryl- or aralkyl-alkyl-hydrazines.
Cignarella G; Barlocco D; Landriani L; Pinna GA; Andriuoli G; Donà G
Farmaco; 1991 Apr; 46(4):527-38. PubMed ID: 1930551
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cicletanine with other antihypertensive drugs in SHR-SP models.
Malherbe E; Le Hegarat M; Clostre F; Braquet P
Drugs Exp Clin Res; 1988; 14(2-3):83-8. PubMed ID: 2970955
[TBL] [Abstract][Full Text] [Related]
15. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS
J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090
[TBL] [Abstract][Full Text] [Related]
16. The effect of indapamide on muscle blood flow in hypertensive patients.
Burgess CD; McKee CE; Wilson CA; Warren DJ
Postgrad Med J; 1981; 57 Suppl 2():23-5. PubMed ID: 7322956
[TBL] [Abstract][Full Text] [Related]
17. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
Armah BI; Hofferber E; Stenzel W
Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
[TBL] [Abstract][Full Text] [Related]
20. The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats.
Rakusan K; Cicutti N; Maurin A; Guez D; Schiavi P
Microvasc Res; 2000 Mar; 59(2):243-54. PubMed ID: 10684730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
